Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma

BMC Cancer

Volumn 9, Issue , 2009, Pages 310-

  Takikita, Mikiko ^a   Hu, Nan ^a   Shou, Jian Zhong ^b   Wang, Quan Hong ^c   Giffen, Carol ^d   Taylor, Philip R ^a   Hewitt, Stephen M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER HOSPITAL   (China)

^c SHANXI CANCER HOSPITAL   (China)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; PROTEIN BCL 2;

ADULT; AGE; ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SMOKING; SURVIVAL TIME; TISSUE MICROARRAY;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; SURVIVAL; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70350273070     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-310     Document Type: Article

References (16)

1. Su H, Hu N, Shih J, Hu Y, Wang Q, Chuang E, Roth M, Wang C, Goldstein A, Ding T. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003, 63(14):3872-3876.
2. Screaton R, Kiessling S, Sansom O, Millar C, Maddison K, Bird A, Clarke A, Frisch S. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci USA 2003, 100(9):5211-5216. 10.1073/pnas.0431215100, 154324, 12702765.
3. Chen G, Bhojani M, Heaford A, Chang D, Laxman B, Thomas D, Griffin L, Yu J, Coppola J, Giordano T. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci USA 2005, 102(35):12507-12512. 10.1073/pnas.0500397102, 1194899, 16109772.
4. Shimada K, Matsuyoshi S, Nakamura M, Ishida E, Konishi N. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression. J Pathol 2005, 206(4):423-432. 10.1002/path.1791, 15906275.
5. Shou J, Hu N, Takikita M, Roth M, Johnson L, Giffen C, Wang Q, Wang C, Wang Y, Su H. Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev 2008, 17(6):1424-1435. 10.1158/1055-9965.EPI-06-0666, 2729558, 18559558.
6. Hu N, Flaig M, Su H, Shou J, Roth M, Li W, Wang C, Goldstein A, Li G, Emmert-Buck M. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004, 10(18 Pt 1):6013-6022. 10.1158/1078-0432.CCR-04-0317, 15447985.
7. Youle R, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008, 9(1):47-59. 10.1038/nrm2308, 18097445.
8. Xue L, Ren L, Luo W, Guan X, Zou S, Zheng S, Bi R, Xie Y, He Z, Lü N. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma]. Zhonghua Yi Xue Za Zhi 2007, 87(3):150-154.
9. Kase S, Osaki M, Adachi H, Kaibara N, Ito H. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Int J Oncol 2002, 20(2):291-297.
10. Shibakita M, Tachibana M, Dhar D, Kotoh T, Kinugasa S, Kubota H, Masunaga R, Nagasue N. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. Clin Cancer Res 1999, 5(9):2464-2469.
11. Chang M, Lee H, Lee B, Kim Y, Lee J, Kim W. Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol Res Pract 2005, 201(6):417-425. 10.1016/j.prp.2005.04.005, 16136747.
12. Shimada K, Nakamura M, Ishida E, Konishi N. Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer. Histol Histopathol 2006, 21(4):415-422.
13. Takayama T, Nagao M, Sawada H, Yamada Y, Emoto K, Fujimoto H, Ueno M, Hirao S, Nakajima Y. Bcl-X expression in esophageal squamous cell carcinoma: association with tumor progression and prognosis. J Surg Oncol 2001, 78(2):116-123. 10.1002/jso.1130, 11579389.
14. Sarbia M, Bittinger F, Porschen R, Verreet P, Dutkowski P, Willers R, Gabbert H. bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus. Int J Cancer 1996, 69(4):324-328. 10.1002/(SICI)1097-0215(19960822)69:4<324::AID-IJC15>3.0.CO;2-5, 8797876.
15. Parenti A, Rugge M, Shiao Y, Ruol A, Ancona E, Bozzola L, Ninfo V. bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer. Histopathology 1997, 31(5):430-435. 10.1046/j.1365-2559.1997.2970888.x, 9416483.
16. Ohbu M, Saegusa M, Kobayashi N, Tsukamoto H, Mieno H, Kakita A, Okayasu I. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 1997, 79(7):1287-1293. 10.1002/(SICI)1097-0142(19970401)79:7<1287::AID-CNCR3>3.0.CO;2-E, 9083148.